Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with α-fetoprotein and protein induced by vitamin K absence or antagonist-II-Reference-Cited by-同舟云学术

Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with α-fetoprotein and protein induced by vitamin K absence or antagonist-II

Published:2006-09 Issue:7 Volume:26 Page:789-795
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Yano Yoichi,Yamashita Fumihiko,Kuwaki Kotaro,Fukumori Kazuta,Kato Osamu,Yamamoto Hiroshi,Ando Eiji,Tanaka Masatoshi,Sata Michio

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2006.01310.x/fullpdf

Reference23 articles.

1. Primary liver cancer: Worldwide incidence and trends

2. Hepatocellular carcinoma: Recent trends in Japan

3. RISK FACTORS IN DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CIRRHOSIS: PROSPECTIVE STUDY OF 613 PATIENTS

4. Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

5. Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma;Frontiers in Microbiology;2024-09-06

2. A cross-sectional study of Iraqi patients investigating HPSE SNPs and the incidence of hepatocellular carcinoma;Journal of Population Therapeutics and Clinical Pharmacology;2023-01-01

3. Heparanase (HPSE) gene polymorphism (rs12503843) contributes as a risk factor for hepatocellular carcinoma (HCC): a pilot study among Egyptian patients;Journal of Genetic Engineering and Biotechnology;2021-01-07

4. Development of up-converting phosphor technology-based lateral flow assay for quantitative detection of serum PIVKA-II: Inception of a near-patient PIVKA-II detection tool;Clinica Chimica Acta;2019-01

5. The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma;Journal of Clinical and Translational Hepatology;2017-05-10